Tenpoint Therapeutics’ Yuvezzi brings a combination approach to presbyopia compared to single mechanisms of action offered by once-daily eye drops from Orasis Pharmaceuticals, Lenz Therapeutics, and ...
Tough new driving rules have been announced by the Government ...
It comes amid the launch of a new road safety strategy by the Government ...
History taking is a core part of the diagnostic process for presbyopia, allowing the eye care professional to identify the classic symptoms of the condition. It is particularly important to gather ...
AbbVie has ended speculation about what it will charge for its newly-approved Vuity therapy for presbyopia, a sight condition characterised by difficulty in focusing on near objects. The company told ...
If you are middle aged and find you have to hold your phone at arm's length to read, you may have presbyopia - a difficulty focusing on close objects that is usually corrected using glasses, contact ...
Although presbyopia is common and expected in people older than 40 years of age, its symptoms are nonspecific (blurred vision, eye strain or headache); therefore, careful consideration of differential ...
Yuvezzi is expected to be available in the second quarter of 2026. The Food and Drug Administration (FDA) has approved Yuvezzi ™ (carbachol and brimonidine tartrate ophthalmic solution) 2.75%/0.1% for ...
Yuvezzi is the first FDA-approved dual-agent eye drop for presbyopia, combining carbachol and brimonidine tartrate. Phase III trials showed Yuvezzi significantly improved near visual acuity without ...
The FDA has approved YUVEZZI, the first dual-agent eye drop, to treat presbyopia, a leading cause of vision loss in adults. The medication uses a fixed-dose combination of carbachol (2.75%) and ...
The Cataltheia Group and its U.S. subsidiary, Bruno Vision Care LLC, a leader in eye health innovation, today announced that the U.S. Food and Drug Administration (FDA) has cleared the first and only ...
Ever have your attention hijacked by something appealing? Research using alcohol cues reveals how this bias works.